TO ASSESS THE EFFECTS OF DURATION OF CARDIOPULMONARY BYPASS ON POST-OPERATIVE RENAL FUNCTION

Authors

  • Shehryar Ghauri Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan. Author
  • Fizah Subhani Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan. Author
  • Tayyab Ali Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan. Author
  • Sumayya Urooj Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan. Author
  • Saba Saif Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan. Author

DOI:

https://doi.org/10.71000/fny50h84

Keywords:

Acute Kidney Injury, Cardiopulmonary Bypass, Creatinine, Kidney Function Tests, Postoperative Complications, Renal Insufficiency, Urea

Abstract

Background: Cardiopulmonary bypass (CPB) is essential for many cardiac surgeries, yet its physiological impact on renal function remains a persistent clinical concern. Prolonged exposure to extracorporeal circulation can increase renal stress due to altered perfusion, inflammatory activation, and hemodynamic fluctuations. Understanding how CPB duration influences early postoperative renal markers is crucial for preventing complications such as acute kidney injury and ensuring better recovery outcomes for cardiac patients.

Objective: To evaluate the association between CPB duration and postoperative renal function among adult cardiac surgery patients.

Methods: A total of 109 patients undergoing cardiac surgery with CPB were included. Renal parameters were recorded after the first 24 postoperative hours in the ICU. The primary variables measured were CPB duration, serum creatinine, blood urea levels, and urine output. Data analysis was performed using SPSS version 23. Mean values and standard deviations were calculated for all quantitative variables. Correlation analysis was employed to determine the strength and significance of the association between CPB duration and renal markers, with p < 0.05 considered statistically significant.

Results: The mean CPB duration was 102.00 ± 33.85 minutes. The mean postoperative creatinine level was 1.1661 ± 0.56801 mg/dl, and the mean urea level was 32.63 ± 10.73 mg/dl. A significant positive correlation was found between CPB duration and both creatinine (r = 0.287, p = 0.003) and urea (r = 0.330, p = 0.001). The mean urine output was 2142.66 ± 392.04 ml, showing a weak negative and non-significant correlation with CPB duration (r = −0.016, p = 0.867).

Conclusion: Longer CPB duration was associated with higher postoperative creatinine and urea levels, reflecting increased renal strain, while urine output showed no significant association. Minimizing CPB duration where clinically feasible may support renal preservation and contribute to improved postoperative outcomes.

Author Biographies

  • Shehryar Ghauri, Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

    Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

  • Fizah Subhani, Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

    Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

  • Tayyab Ali, Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

    Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

  • Sumayya Urooj, Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

    Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

  • Saba Saif, Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

    Chaudhary Prevaiz Elahi Institute of Cardiology, Multan, Pakistan.

References

Singh W, Yalamuri S, Nikravangolsefid N, Suppadungsuk S, Goyal S, Hanson A, et al. Ultrafiltration During Cardiac Surgery Requiring Cardiopulmonary Bypass and Its Effect on Acute Kidney Injury. J Cardiothorac Vasc Anesth. 2025;39(1):104-11.

Velho TR, Pinto F, Ferreira R, Pereira RM, Duarte A, Harada M, et al. Role of major cardiovascular surgery-induced metabolic reprogramming in acute kidney injury in critical care. Intensive Care Med. 2025;51(2):259-71.

Landoni G, Monaco F, Ti LK, Baiardo Redaelli M, Bradic N, Comis M, et al. A Randomized Trial of Intravenous Amino Acids for Kidney Protection. N Engl J Med. 2024;391(8):687-98.

Monaco F, Lei C, Bonizzoni MA, Efremov S, Morselli F, Guarracino F, et al. A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery. N Engl J Med. 2025;393(5):450-60.

Karkouti K, Callum JL, Bartoszko J, Tanaka KA, Knaub S, Brar S, et al. Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery: The FARES-II Multicenter Randomized Clinical Trial. Jama. 2025;333(20):1781-92.

Milne B, Gilbey T, Kunst G. Perioperative Management of the Patient at High-Risk for Cardiac Surgery-Associated Acute Kidney Injury. J Cardiothorac Vasc Anesth. 2022;36(12):4460-82.

Sunthankar SD, Hill KD, Jacobs JP, Baldwin HS, Jacobs ML, Li JS, et al. Methylprednisolone for Infant Heart Surgery: Subpopulation Analyses of a Randomized Controlled Trial. Crit Care Med. 2025;53(7):e1470-e80.

Kamla CE, Meersch-Dini M, Palma LMP. Kidney Injury Following Cardiac Surgery: A Review of Our Current Understanding. Am J Cardiovasc Drugs. 2025;25(3):337-48.

Pontillo D, Rong LQ, Pruna A, Pisano A, Monaco F, Bruni A, et al. Impact of Cardiopulmonary Bypass Duration on the Renal Effects of Amino Acids Infusion in Cardiac Surgery Patients. J Cardiothorac Vasc Anesth. 2025;39(9):2296-306.

Maruniak S, Loskutov O, Swol J, Todurov B. Factors associated with acute kidney injury after on-pump coronary artery bypass grafting. J Cardiothorac Surg. 2024;19(1):598.

Pérez-Fernández X, Ulsamer A, Cámara-Rosell M, Sbraga F, Boza-Hernández E, Moret-Ruíz E, et al. Extracorporeal Blood Purification and Acute Kidney Injury in Cardiac Surgery: The SIRAKI02 Randomized Clinical Trial. Jama. 2024;332(17):1446-54.

Sasaki J, Rodriguez Z, Alten JA, Rahman AF, Reichle G, Lin P, et al. Epidemiology of Neonatal Acute Kidney Injury After Cardiac Surgery Without Cardiopulmonary Bypass. Ann Thorac Surg. 2022;114(5):1786-92.

Jia P, Ji Q, Zou Z, Zeng Q, Ren T, Chen W, et al. Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial. Circulation. 2024;150(17):1366-76.

Barbu M, Hjärpe A, Martinsson A, Dellgren G, Ricksten SE, Lannemyr L, et al. Cardiopulmonary bypass management and acute kidney injury in cardiac surgery patients. Acta Anaesthesiol Scand. 2024;68(3):328-36.

Yang X, Zhu L, Pan H, Yang Y. Cardiopulmonary bypass associated acute kidney injury: better understanding and better prevention. Ren Fail. 2024;46(1):2331062.

Li Q, Lv H, Chen Y, Shen J, Shi J, Zhou C. Association between iron metabolism and acute kidney injury in cardiac surgery with cardiopulmonary bypass: a retrospective analysis from two datasets. BMC Nephrol. 2024;25(1):416.

Ostermann M, Shaw AD. Amino Acid Infusion to Protect Kidney Function after Cardiac Surgery. N Engl J Med. 2024;391(8):759-60.

Milne B, Gilbey T, De Somer F, Kunst G. Adverse renal effects associated with cardiopulmonary bypass. Perfusion. 2024;39(3):452-68.

Djordjević A, Šušak S, Velicki L, Antonič M. ACUTE KIDNEY INJURY AFTER OPEN-HEART SURGERY PROCEDURES. Acta Clin Croat. 2021;60(1):120-6.

Chen L, Sun J, Kong S, Tan Q, Liu X, Cheng Y, et al. Acute kidney disease and postoperative glycemia variability in patients undergoing cardiac surgery: A multicenter cohort analysis of 8,090 patients. J Clin Anesth. 2025;100:111706.

D. Janssen, L. Noyez, J.A. van Druten, S.H. Skotnicki, L.K. Lacquet Predictors of nephrological morbidity after coronary artery bypass surgery Cardiovasc Surg, 10 (2022), pp. 222-227

D. Lau, N. Pannu, M.T. James, B.R. Hemmelgarn, T.M. Kieser, S.R. Meyer, et al. Costs and consequences of acute kidney injury after cardiac surgery: a cohort study J Thorac Cardiovasc Surg. 162 (2021), pp. 880-887

Downloads

Published

2025-11-22